Combination therapy of HSP90 inhibitors and PD-1 inhibitors for treating cancer
US-11497733-B2 · Nov 15, 2022 · US
Synta Pharmaceuticals Corp holds 75 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 75 |
| Recent patents | 0 |
| First publication | Jan 1, 2015 |
| Latest publication | Nov 15, 2022 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-11497733-B2 · Nov 15, 2022 · US
US-11154538-B2 · Oct 26, 2021 · US
US-10500193-B2 · Dec 10, 2019 · US
US-2019144398-A1 · May 16, 2019 · US
US-2019060285-A1 · Feb 28, 2019 · US
Representative or frequently cited publications from precomputed assignee stats.
US-11497733-B2 · Nov 15, 2022 · US
US-11154538-B2 · Oct 26, 2021 · US
US-10500193-B2 · Dec 10, 2019 · US
US-2019144398-A1 · May 16, 2019 · US
US-2019060285-A1 · Feb 28, 2019 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 64 |
| A61K31/4196 | 39 |
| A61P43/00 | 34 |
| A61P29/00 | 27 |
| C07D403/04 | 22 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 75 |
| Chemistry & Metallurgy | 51 |
| Cross-Sectional Technologies | 13 |
| Physics | 6 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.